S6G5T-3 / Sol-Gel 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
  • ||||||||||  Twyneo (3% microencapsulated benzoyl peroxide/0.1% microencapsulated tretinoin) - Sol / Gel
    Clinical, Review, Journal:  Tretinoin 0.1% and Benzoyl Peroxide 3% Cream for the Treatment of Facial Acne Vulgaris. (Pubmed Central) -  Jan 15, 2023   
    Tretinoin 0.1%-benzoyl peroxide 3% cream is safe and effective for the treatment of moderate-to-severe acne. Long-term trial data on efficacy and tolerability are not yet available.
  • ||||||||||  S6G5T-3 - Sol / Gel
    Trial completion, Trial completion date:  A Study of S6G5T-3 in the Treatment of Acne Vulgaris (clinicaltrials.gov) -  Mar 18, 2020   
    P3,  N=424, Completed, 
    Long-term trial data on efficacy and tolerability are not yet available. Recruiting --> Completed | Trial completion date: Dec 2020 --> Dec 2019
  • ||||||||||  S6G5T-3 - Sol / Gel
    Trial completion, Trial completion date:  A Study of S6G5T3 in the Treatment of Acne Vulgaris (clinicaltrials.gov) -  Mar 18, 2020   
    P3,  N=434, Completed, 
    Recruiting --> Completed | Trial completion date: Dec 2020 --> Dec 2019 Recruiting --> Completed | Trial completion date: Nov 2020 --> Dec 2019
  • ||||||||||  S6G5T-3 - Sol / Gel
    Enrollment open:  A Study of S6G5T-3 in the Treatment of Acne Vulgaris (clinicaltrials.gov) -  Jul 9, 2019   
    P3,  N=420, Recruiting, 
    Recruiting --> Completed Not yet recruiting --> Recruiting
  • ||||||||||  S6G5T-3 - Sol / Gel
    Enrollment open:  A Study of S6G5T3 in the Treatment of Acne Vulgaris (clinicaltrials.gov) -  Jul 9, 2019   
    P3,  N=420, Recruiting, 
    Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
  • ||||||||||  S6G5T-3 - Sol / Gel, Twyneo (3% microencapsulated benzoyl peroxide/0.1% microencapsulated tretinoin) - Sol / Gel
    Trial completion, Trial primary completion date:  Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris (clinicaltrials.gov) -  Oct 4, 2017   
    P2,  N=660, Completed, 
    Not yet recruiting --> Recruiting Active, not recruiting --> Completed | Trial primary completion date: Jul 2017 --> Oct 2017
  • ||||||||||  S6G5T-3 - Sol / Gel, Twyneo (3% microencapsulated benzoyl peroxide/0.1% microencapsulated tretinoin) - Sol / Gel
    Enrollment closed:  Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris (clinicaltrials.gov) -  May 31, 2017   
    P2,  N=660, Active, not recruiting, 
    Active, not recruiting --> Completed | Trial primary completion date: Jul 2017 --> Oct 2017 Recruiting --> Active, not recruiting